Track the Arctic Bioscience AS stock price and the full directors' dealings record of the company, a listed issuer based in Norway. Shares are listed on NO NO, under the supervision of Oslo Børs. Operating in the Health Care sector, Arctic Bioscience AS has logged 56 reports. Market capitalisation: €87.6m. The latest transaction was filed on 1 April 2026 (Sale). Among the most active insiders: Jone R. Slinning. Every trade is free.
56
Insider Decl.
0
Thresholds
€929m
39 ops.
Buy Volume
€5m
9 ops.
Sell Volume
22Σ signal
Buys €929m€5m Sells
Fundamental score
Ranked 24,767 of 25,973 companies
15.3
score / 100
Value
5
Quality
26
FCF yld-52%
Earn yld-47%
EV/EBITDA·
ROE-21%
Gross mgn28%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 shares@ NOK 10.50100.0% of flowShareMERKOSLO:622957
Ideal exit: 29 Mar 2025 (T+270)
25 of 56 declarations
About Arctic Bioscience AS
Arctic Bioscience AS is a company focused on the health and pharmaceutical sector, dedicated to developing innovative solutions for human health. It is listed on the XOSL market.